Accel-KKR Backs Staritas Spinout to Advance Healthcare Spend Management

ECRI, a global nonprofit focused on healthcare quality and safety, announces the spinout of its Spend Management and Recall Management solutions into an independent company named Staritas. The transition, announced on April 21, 2026, is backed by a growth investment from Accel-KKR, a technology-focused private equity firm.

Staritas inherits five decades of ECRI’s expertise in healthcare supply chain intelligence, providing data-driven solutions that help healthcare organizations optimize spend and manage product recalls. Nearly 90% of the top U.S. hospitals and health systems rely on Staritas’ platform, which identifies up to $13 billion in annual opportunity savings for customers worldwide.

Marcus Schabacker, CEO and president of ECRI, highlights the strategic rationale: “By spinning out Staritas and partnering with Accel-KKR, we aim to supercharge the platform’s data capabilities, enhance user experience, and accelerate innovation to deliver greater value to healthcare supply chain leaders.”

Staritas combines the largest independent healthcare supply and capital datasets with advanced analytics to provide actionable insights. Emmet O’Gara, CEO of Staritas, emphasizes the company’s commitment to continuous advancement: “We plan to raise the bar with next-generation technology that protects margins, supports quality care, and boosts supply chain resiliency.”

Accel-KKR, with over $23 billion in capital commitments, specializes in software and tech-enabled businesses. Park Durrett, Managing Director at Accel-KKR, states, “Staritas’ unmatched datasets and domain expertise provide a strong foundation for growth. We are proud to support the company’s mission to deliver transparent, independent insights that empower healthcare organizations globally.”

The spinout allows ECRI to sharpen its focus on patient safety, clinical evidence, and healthcare system resilience. Dr. Schabacker adds, “This is not a departure but a recommitment to advancing patient safety and evidence-based care through dedicated investments in expert teams and proprietary data.”

Staritas will maintain operational continuity for existing customers while accelerating platform enhancements and expanding its market reach. The company’s solutions address rising healthcare costs, supply chain complexity, and margin pressures by enabling proactive, AI-powered decision-making.

Industry experts note that the healthcare supply chain sector is evolving toward integrated, data-driven strategies. Staritas’ combined spend and recall management capabilities position it to capitalize on this trend, potentially increasing market share and setting higher competitive standards.

Looking ahead, Staritas plans to leverage Accel-KKR’s network to expand its customer base and accelerate product innovation. Integration challenges such as aligning technology roadmaps and ensuring regulatory compliance remain priorities to safeguard customer satisfaction and data security.

Overall, the spinout and investment mark a significant step in transforming healthcare supply chain management, with Staritas poised to deliver enhanced value through advanced analytics and independent data intelligence.